The Lung Cancer Research Foundation (LCRF) has announced three research grant awards focused on the further understanding of the mechanism of action of antibody drug conjugates (ADCs) and exploring the use of ADCs in lung cancer types beyond NSCLC.
[Lung Cancer Research Foundation]
